Maduva Life Sciences Acquires 50% Shares of Medicatech, Leading Radiation Protection Equipment Manufacturer and now Medicatech is Cubithera Instruments

Transformation to Cubithera Instruments Marks the Beginning of Global Expansion

Istanbul, September 7th,2023  — Maduva Life Sciences is excited to announce the successful acquisition of a 50% stake in Medicatech, a prominent manufacturer of radiation protection equipment in Turkey. This strategic collaboration ushers in a new era of innovation and growth, as the company takes its first step towards expanding its footprint on a global scale. Following the merger, the company will be rebranded as Cubithera Instruments, signifying a fusion of cutting-edge technology and a commitment to advancing healthcare solutions.

Medicatech has been a pioneer in the design and production of specialized hotcells, particularly for theranostic applications, catering to the evolving needs of the medical and research communities. This acquisition allows Maduva Life Sciences to leverage its expertise and resources, combining forces to create an even more formidable presence in the radiation protection equipment sector.

The decision to rebrand the merged entity as Cubithera Instruments reflects a strategic alignment of values, goals, and aspirations. While we embark on this exciting journey, we are committed to preserving the legacy and relationships built by Medicatech. The new name symbolizes our dedication to innovation, precision, and seamless integration of technology to empower professionals working in nuclear medicine and related fields.

“We are thrilled about the acquisition of Medicatech and the subsequent transformation into Cubithera Instruments. This marks a significant milestone in our efforts to provide top-notch radiation protection solutions globally. We are dedicated to ensuring a smooth transition for our existing shareholders and partners as we embark on this exciting phase of growth,” stated Arda Karaduman,Managing Director at Maduva Life Sciences.

Equally enthusiastic about this new phase, Ozkan Gunay, Founder and Managing Director at Medicatech, commented, “The acquisition by Maduva Life Sciences marks a significant chapter in the story of Medicatech. We are proud of the strides we’ve taken in the field of radiation protection, and we are confident that this collaboration will only enhance our capabilities. As we transition to become Cubithera Instruments, we remain committed to the values that have guided us thus far.”

Cubithera Instruments is poised to deliver a comprehensive range of radiation protection solutions, with an unwavering commitment to product quality, safety, and customer satisfaction. Our expanded capabilities and international presence will allow us to better serve the needs of our valued clients, ensuring their access to state-of-the-art equipment and services. The acquisition and rebranding process will be executed with utmost care to ensure minimal disruption to existing operations and relationships. Maduva Life Sciences and Cubithera Instruments are grateful for the trust and confidence that clients, partners, and shareholders

Ready to explore the possibilities?

Have questions, need a quote, or want to discuss a project? We're here to assist you with all your needs in the field of radioactive drug production and more...

+90 216 606 5331

Let's discuss the details